TP53 and central nervous system cancer: The reasons for this difference might be that Xu et al. did not distinguish the discrepancy of prognosis and genes expression between LGG and GBM, and they had not considered the effects of IDH mutation, TP53 mutation, ATRX mutation and 1p19q on the prognosis of glioma.